Biogen (BIIB)

Depreciation & Amortization

$842.90M

TTM · Period ending: · USD

BIIB logo

BIIB Depreciation & Amortization

Latest reported$842.90M
BIIB TTM Depreciation & Amortization (-$3.80M → $842.90M)
High-resolution chart · PNG

BIIB depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Biogen Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
842,900,000
801,100,000
779,900,000
763,700,000
744,300,000
708,900,000
673,200,000
629,300,000
571,500,000
530,000,000
494,800,000
474,500,000
470,200,000
487,600,000
518,400,000
533,300,000
545,800,000
528,200,000
487,700,000
462,500,000
444,000,000
439,700,000
457,000,000
460,500,000
459,300,000
463,400,000
464,600,000
504,600,000
548,300,000
602,800,000
650,600,000
675,400,000
695,600,000
706,700,000
1,049,800,000
1,049,400,000
1,052,200,000
1,045,000,000
682,700,000
661,600,000
633,000,000
602,200,000
600,400,000
601,742,000
625,548,000
645,087,000
688,150,000
688,891,000
660,962,000
625,250,000
531,740,000
470,233,000
416,959,000
379,156,000
365,648,000
357,493,000
350,657,000
350,333,000
358,933,000
364,224,000
366,985,000
364,136,000
354,101,000
353,289,000
349,045,000
388,325,000
427,961,000
456,778,000
498,465,000
477,273,000
462,059,000
442,305,000
411,489,000
398,410,000
380,293,000
365,247,000
358,223,000
341,455,000
375,870,000
386,177,000
406,197,000
429,327,000
402,208,000
411,143,000
431,026,000
433,760,000
439,435,000
349,390,000
223,613,000
125,060,000
26,374,000
23,703,000
30,673,000
58,646,000
65,992,000
61,049,000
96,405,000
74,722,000
73,053,000
81,193,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.